• Impact of nutraceuticals on markers of systemic inflammation : potential relevance to cardiovascular diseases - A position paper from the International Lipid Expert Panel (ILEP)Ruscica, Massimiliano; Penson, Peter E.; Ferri, Nicola; Sirtori, Cesare R.; Pirro, Matteo; Viigimaa, MargusProgress in Cardiovascular Diseases2021 / p. 40-52 https://doi.org/10.1016/j.pcad.2021.06.010 https://www.scopus.com/sourceid/20552 https://www.scopus.com/record/display.uri?eid=2-s2.0-85109445846&origin=inward&txGid=99fc581435d3692bf32bedaaef2d1182 https://jcr.clarivate.com/jcr-jp/journal-profile?journal=PROG%20CARDIOVASC%20DIS&year=2022 https://www.webofscience.com/wos/woscc/full-record/WOS:000686978200008
• 2022: The year in cardiovascular disease - the year of upfront lipid lowering combination therapyBanach, Maciej; Reiner, Zeljko; Cicero, Arrigo F.G.; Sabouret, Pierre; Viigimaa, Margus; Sahebkar, Amirhossein; Postadzhiyan, Arman; Gaita, Dan; Pella, Daniel; Penson, Peter E.Archives of Medical Science2022 / p. 1429-1434 : ill https://doi.org/10.5114/aoms/156147 https://www.scopus.com/sourceid/4000151806 https://www.scopus.com/record/display.uri?eid=2-s2.0-85142920691&origin=inward&txGid=13cf55092dc5bc705699649b9275baec https://jcr.clarivate.com/jcr-jp/journal-profile?journal=ARCH%20MED%20SCI&year=2022 https://www.webofscience.com/wos/woscc/full-record/WOS:000892482200002